Rating Change
JP Morgan analysts upgraded Expeditors International of Washington, Inc. (NYSE:EXPD) from Underweight to Neutral on August 05, 2026.
Rating Change JP Morgan analysts upgraded Expeditors International of Washington, Inc. (NYSE:EXPD) from Underweight to Neutral on August 05, 2026. Market Context Expeditors…

JP Morgan analysts upgraded Expeditors International of Washington, Inc. (NYSE:EXPD) from Underweight to Neutral on August 05, 2026.
Expeditors International of Washington, Inc. operates in the Industrials sector. The stock currently trades at $181.41 with a market capitalization of $21.0B. The stock has gained 31.2% over the past 52 weeks.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. JP Morgan's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 3 Buy, 4 Hold, 3 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | TD Cowen | Sell | N/A |
| Aug 05, 2026 | Barclays | Underweight | N/A |
| Aug 05, 2026 | JP Morgan | Neutral | N/A |
| Jul 21, 2026 | B of A Securities | Buy | N/A |
| Jul 15, 2026 | Truist Securities | Hold | N/A |
Related Tools: Analyst Ratings Dashboard | View EXPD Stock Page
A Neutral rating from JP Morgan reflects the analyst's outlook on Expeditors International of Washington, Inc. (NYSE:EXPD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the EXPD forecast page.
Current market data
NYSE · EXPD
Keep reading
analyst ·
analyst ·
earnings ·
price ·